Antihistamine acquired from Alimera Sciences

February 15, 2007

Rochester, NY-Bausch & Lomb has purchased Alimera Sciences' over-the-counter allergy franchise, including ketotifen fumarate ophthalmic solution 0.025% (Alaway), which was recently approved by the FDA.

Rochester, NY-Bausch & Lomb has purchased Alimera Sciences' over-the-counter allergy franchise, including ketotifen fumarate ophthalmic solution 0.025% (Alaway), which was recently approved by the FDA.

The ophthalmic solution is an antihistamine designed to provide up to 12 hours of relief for itchy eyes caused by ragweed, pollen, animal hair, and dander. Bausch & Lomb's Gary M. Phillips, MD, corporate vice president, said the transaction would give the company a technology platform on which to build ocular allergy product line extensions.

Terms of the deal were not disclosed.

Related Content:

Pharmacy